Remicade Ulcerative Colitis Indication Expands To Maintenance Therapy
This article was originally published in The Pink Sheet Daily
Executive Summary
Remicade becomes the only biologic indicated for inducing and maintaining clinical remission of ulcerative colitis and Crohn’s disease, according to Centocor.